In This Section

Precision Combination Therapy Task Force

The AACR Precision Combination Therapy Task Force convenes a diverse group of experts engaged in clinical and translational research to analyze the current state of combination therapies, identify innovative solutions to optimize and standardize clinical trial design, and assist in guiding the AACR’s ongoing and future programs and initiatives to educate and train clinical researchers about the complexities and opportunities of cancer combination therapy trials.

Chair

Elizabeth M. Jaffee, MD, FAACR

(2021-2023)

Deputy Director and Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Co-chair

Jennifer Rubin Grandis, MD

(2021-2023)

Robert K. Werbe Distinguished Professor in Head and Neck Cancer
University of California San Francisco
San Francisco, California

Co-chair

Albert C. Koong, MD, PhD

(2021-2023)

Professor
UT MD Anderson Cancer Center
Houston, Texas

Co-chair

Patricia M. LoRusso, DO, PhD (hc)

(2021-2023)

Associate Director of Innovative Medicine
Professor of Medicine
Yale School of Medicine
New Haven, Connecticut

Co-chair

Antoni Ribas, MD, PhD

(2021-2023)

Professor of Medicine, Surgery, Molecular and Medical Pharmacology
Director, Tumor Immunology Program
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California

Alex A. Adjei, MD, PhD

(2021-2023)

Professor
Mayo Clinic
Rochester, Minnesota

Kenneth C. Anderson, MD, PhD (hc), FAACR

(2021-2023)

Kraft Family Professor of Medicine, Harvard Medical School
Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Dana-Farber Cancer Institute
Boston, Massachusetts

Anna D. Barker, PhD, FAACR

(2021-2023)

Chief Strategy Officer
Ellison Institute for Transformative Medicine
Los Angeles, California

Peter L. Choyke, MD

(2021-2023)

Senior Investigator
National Cancer Institute
Bethesda, Maryland

Marcia R. Cruz-Correa, MD, PhD

(2021-2023)

Professor of Medicine, Biochemistry, and Oncology
University of Puerto Rico School of Medicine
San Juan, Puerto Rico

Sandra Demaria, MD

(2021-2023)

Professor of Radiation Oncology and Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, New York

James H. Doroshow, MD

(2021-2023)

Director, NCI Division of Cancer Treatment and Diagnosis
Bethesda, Maryland

Laura J. Esserman, MBA, MD

(2021-2023)

Alfred A. de Lorimier Endowed Chair in General Surgery
Professor, Departments of Surgery and Radiology, and Affiliate Faculty, Institute for Health Policy Studies, UCSF
Director, UCSF Breast Care Center
Co-Leader, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California

Katherine W. Ferrara, PhD

(2021-2023)

Division Chief, Molecular Imaging Program
Professor of Radiology
Stanford University
Stanford, California

Silvia C. Formenti, MD

(2021-2023)

Chairman, Department of Radiation Oncology
Associate Director, Meyer Cancer Center
Radiation Oncologist-in-Chief, NewYork-Presbyterian Hospital
New York, New York

Thomas J. Kipps, MD, PhD

(2021-2023)

Deputy Director of Research and Professor of Medicine
UCSD Moores Cancer Center
La Jolla, California

Massimo Loda, MD

(2021-2023)

David D. Thompson Professor and Chair, Department of Pathology and Laboratory Medicine
Pathologist-in-Chief
NewYork-Presbyterian/Weill Cornell Medical Center
New York, New York

Crystal L. Mackall, MD

(2021-2023)

Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine
Stanford Hospital
Stanford, California

Rita Nanda, MD

(2021-2023)

Associate Professor of Medicine, Director, Breast Oncology
University of Chicago
Chicago, Illinois

Robert S. Negrin, MD

(2021-2023)

Professor of Medicine
Stanford Hospital
Stanford, California

Lisa A. Newman, MD, MPH

(2021-2023)

Chief
Weill Cornell Medicine
New York, New York

Kunle Odunsi, MD, PhD

(2021-2023)

Director
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois

Anil Vasdev Parwani, MD, PhD

(2021-2023)

Professor of Pathology, Vice Chair and Director, Anatomical Pathology
The Ohio State University Wexner Medical Center
Columbus, Ohio

Mary W. Redman, PhD

(2021-2023)

Professor
Fred Hutchinson Cancer Research Center
Seattle, Washington

Kurt Alex Schalper, MD, PhD

(2021-2023)

Assistant Professor of Pathology and Medicine
Yale University
New Haven, Connecticut

Yu Shyr, PhD

(2021-2023)

Chair, Department of Biostatistics
Harold L. Moses Chair in Cancer Research
Director, Vanderbilt Center for Quantitative Sciences
Director, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design
Professor of Biostatistics, Biomedical Informatics, and Health Policy
Vanderbilt University Medical Center
Nashville, Tennessee

Louis M. Staudt, MD, PhD, FAACR

(2021-2023)

Chief, Lymphoid Malignancies Branch
NIH Distinguished Investigator
Director, Center for Cancer Genomics
Bethesda, Maryland

Charles Swanton, MBPhD, FAACR

(2021-2023)

Royal Society Napier Professor and Senior Group Leader
The Francis Crick Institute
London, England

Marc R. Theoret, MD

(2021-2023)

Deputy Director, Oncology Center of Excellence
Food and Drug Administration
Silver Spring, Maryland

David A. Tuveson, MD, PhD, FAACR

(2021-2023)

Director and Roy J. Zuckerberg Professor of Cancer Research
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

Eliezer M. Van Allen, MD

(2021-2023)

Chief, Division of Population Sciences
Associate Professor of Medicine, Harvard Medical School
Associate Member, Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Boston, Massachusetts

Jennifer A. Wargo, MD

(2021-2023)

Professor
UT MD Anderson Cancer Center
Houston, Texas

Timothy A. Yap, MD, PhD

(2021-2023)

Timothy A. Yap, MD, PhD
Associate Professor
UT MD Anderson Cancer Center
Houston, Texas

Contact Information

Kathryn Leonard, PhD
Phone: 215-309-4356
Email: [email protected]